Levodopa Market Reviewed in Latest Study 2021 Research Report With Forecast Estimation 2027
The Levodopa Market analysis report speaks about the growth rate till 2027 manufacturing process, Growth, key factors driving this market with sales, revenue, and price analysis of lead manufacturers, distributors, traders and dealers of Levodopa.
Levodopa also referred as L-Dopa is the chemical building-block, which converts to dopamine within the body. The dopamine is the chemical messenger which is released in the brain that is responsible for mediating pleasure, memory functions, and cognition. Almost, all patients get the levodopa – the dopamine precursor, which adequately controls Parkinson’s disease (PD) symptoms at the disease’s early stage. Often the carbidopa is combined with drugs containing levodopa to increase its efficacy through slowing the dopamine’s metabolism down.
The prominent players in the Levodopa Market are Taj Pharmaceuticals Limited., Guangzhou HanFang Pharmaceutical Company Limited, Poulvet.com, Teva Pharmaceutical Industries Ltd., UBM, Zhejiang Wild Wind Pharmaceutical Co., Ltd., and SWAPNROOP.
Developments in innovative formulations along with methods for efficient drug delivery for levodopa are expected to propel the global levodopa market growth over the forecast period. For instance, there is an ongoing clinical trial for Phase III for the gastric retentive pill Accordion, which is an instant formulation of drug release from Intec Pharma Ltd., the trial is expected to be over in September 2018. Accordion Pill is the Carbidopa/Levodopa (AP-CD/LD) combinational oral system of drug delivery that is designed for improving the safety and efficacy of existing CD/LD drugs with the use of a particular release mechanism and efficient gastric retention and.
Furthermore, Impel NeuroPharma Inc. is performing the clinical study of phase II for INP103, a combination drug-device product consisting of the L-dopa drug component, and the I231 Precision Olfactory Delivery (POD) device component. This study is expected to be finished till November 2018.
Moreover, advancements in Parkinson’s disease (PD) progression’s diagnosis, is expected to drive global levodopa market growth over the forecast period. For instance, the clinical study carried out by Washington University School of Medicine, to measure PD progression both by utilizing Magnetic Resonance Imaging (MRI) and by levodopa’s controlled dose for discovering PD’s suitable biomarker is presently in phase I clinical trial and is expected to complete by February 2019.
Buy This Complete A Business Report With Flat US $2000 Off @
Drug supply shortage within the market owing to supply and manufacturing delays of levodopa is expected to restrain growth of the global levodopa market during the forecast period. For instance, in September 2018, Merck Sharp & Dohme Ireland (Human Health) Ltd. projected stock shortage of certain products of Sinemet (Carbidopa/ Levodopa) within the market of Ireland in the near future owing to delays in global manufacturing and demands for resupplying these products.
Based on region, the global levodopa market is segregated into North America, Europe, Latin America, Asia Pacific, Africa and Middle East.
North America is expected to hold a dominant position in the global levodopa market, due to latest product approvals from the U.S. Food and Drug Administration (FDA). For instance, the U.S. FDA, in 2015, approved Duopa which is an extended-release oral Levodopa/Carbidopa formulation, developed by AbbVie Inc., within the U.S. market. The Duopa is Carbidopa/Levodopa’s gel formulation of enteral suspension that is administered with the help of a portable, small infusion pump which directly delivers Levodopa and Carbidopa to the small intestine, which is constantly released for above 16 hours within the body.
Europe is expected to register robust growth in the global levodopa market, owing to presence of major players for novel formulation’s marketing in the region. For instance, in March 2018, Acorda Therapeutics, Inc., presented a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for INBRIJA, which is a treatment of investigational inhaled levodopa for OFF period symptoms (OFF symptoms suggest the recurring symptoms including tremors and rigidity, after levodopa use for long periods) in PD patients undergoing a regimen of Carbidopa/Levodopa.
Furthermore, Impax Laboratories, Inc., in November 2015, received the marketing authorization from European Commission (EC) for a modified-release formulation of oral capsule – NUMIENT (Levodopa and Carbidopa), for symptomatically treating of adult Parkinson’s disease patients in the European region.
Major players functioning in the global levodopa market are, Taj Pharmaceuticals Limited., Teva Pharmaceutical Industries Ltd., Guangzhou HanFang Pharmaceutical Company Limited, UBM, Poulvet.com, SWAPNROOP and Zhejiang Wild Wind Pharmaceutical Co., Ltd.
Main points in Levodopa Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Levodopa Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Levodopa Industry Impact
Chapter 2 Global Levodopa Competition by Types, Applications, and Top Regions and Countries
2.1 Global Levodopa (Volume and Value) by Type
2.3 Global Levodopa (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Levodopa Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Levodopa Market Analysis
Chapter 6 East Asia Levodopa Market Analysis
Chapter 7 Europe Levodopa Market Analysis
Chapter 8 South Asia Levodopa Market Analysis
Chapter 9 Southeast Asia Levodopa Market Analysis
Chapter 10 Middle East Levodopa Market Analysis
Chapter 11 Africa Levodopa Market Analysis
Chapter 12 Oceania Levodopa Market Analysis
Chapter 13 South America Levodopa Market Analysis
Chapter 14 Company Profiles and Key Figures in Levodopa Business
Chapter 15 Global Levodopa Market Forecast (2021-2027)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire